hotspot -WSS

hotspot

author：entertainment 2025-09-03 14:38:41 - browse：15224

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

focus

WSS

NIH fellows want a pay raise. Will that mean less money for grants?

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Palantir health business leans on meeting customers’ needs

Lecanemab for Alzheimer's is coming. Is the health system ready?

Medical mystery: When an infection after surgery isn’t what it seems

How the political right came to back psychedelics to treat trauma

entertainment

hotspot

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Malaria cases in Florida and Texas: Here’s what you need to know

Calls for Trump's election interference trial to be televised part of long debate

Virginia high school admissions case could be legal follow

Special counsel alerts court to Trump’s social media post

Anesthesiologist group: stop taking Ozempic before surgery

Why 40% Americans with Parkinson’s don’t see a neurologist

Medicare details structure of new drug price negotiation program

A new study sees potential in DNA sequencing of infants

hotspot

'Cuddling' is just what the doctor ordered for a 200

California Joshua trees severely burned in massive wildfire

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Russian court extends detention of American musician

Petition to FDA: Get the lead out of consumer hair dyes

Eat, drink, but be wary — 4 foods that interact with medications

Wikipedia

focus

hotspot

knowledge